SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-019207
Filing Date
2019-09-27
Accepted
2019-09-27 17:08:38
Documents
1
Period of Report
2019-09-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k092619_delmarpharma.htm 8-K 20817
  Complete submission text file 0001213900-19-019207.txt   22032
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 191122841
SIC: 2834 Pharmaceutical Preparations